Germany was IM Cannabis’s largest region in fiscal 2025, bringing in $36.35M of $54.73M (66%).
| Geography | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Israel | $50.50M | $43.32M | $38.52M | $18.38M | |||
| Germany | $3.84M | $5.49M | $15.51M | $36.35M | |||
| Total | $54.34M | $48.80M | $54.03M | $54.73M |
IM Cannabis brought in $54.73M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 1.3% from $54.03M in fiscal 2024. Germany was the largest at $36.35M (66.4%), ahead of Israel at $18.38M (33.6%).
Compared with fiscal 2024, Germany grew 134.4% to $36.35M, while Israel fell 52.3% to $18.38M. From fiscal 2022 to 2025, combined revenue from these regions grew from $54.34M to $54.73M, a compound annual growth rate of 0.2%. Germany's share of the total rose from 7.1% to 66.4%.
Cannabis Products was IM Cannabis’s largest revenue line in fiscal 2025, bringing in $53.19M of $54.73M (97%).
| Products and services [axis] | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Cannabis Products | $48.38M | $44.25M | $51.34M | $53.19M |
| Other Cannabis | $5.95M | $4.56M | $2.70M | $1.55M |
| Total | $54.34M | $48.80M | $54.03M | $54.73M |
IM Cannabis brought in $54.73M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 1.3% from $54.03M in fiscal 2024. Cannabis Products was the largest at $53.19M (97.2%), ahead of Other Cannabis at $1.55M (2.8%).
Compared with fiscal 2024, Cannabis Products grew 3.6% to $53.19M, while Other Cannabis fell 42.7% to $1.55M. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $54.34M to $54.73M, a compound annual growth rate of 0.2%. Cannabis Products' share of the total rose from 89.0% to 97.2%.
IM Cannabis (IMCC) reports its revenue by geography and by products and services [axis]. In fiscal 2025, Germany was its largest region, bringing in $36.35M (66.4% of the total), followed by Israel at $18.38M (33.6%).
Germany was IM Cannabis' largest region in fiscal 2025, bringing in $36.35M, or 66.4% of the $54.73M total across its two regions.
Cannabis Products was IM Cannabis' largest revenue line in fiscal 2025, bringing in $53.19M, or 97.2% of the $54.73M total across its two revenue lines.
Germany grew faster than Israel in fiscal 2025, up 134.4% from $15.51M to $36.35M. Israel fell 52.3% to $18.38M.
Every figure comes from IM Cannabis' annual financial filings, as reported. Each line keeps the name IM Cannabis gives it, and years follow its fiscal calendar.
IM Cannabis' revenue by geography goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.